J.P. Morgan analyst Anupam Rama maintains $Amicus Therapeutics (FOLD.US)$ with a buy rating.
According to TipRanks data, the analyst has a success rate of 48.2% and a total average return of 4.0% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Amicus Therapeutics (FOLD.US)$'s main analysts recently are as follows:
Amicus' third quarter revenues exceeded Street forecasts, boasting $120.4M from Galafold sales and $21.1M from purchase order sales. Post-results, adjustments were made to the financial model for the quarter, along with an update to the guidance and a shift of the discount year to 2025. Additionally, the cost of goods sold was revised upwards, reflecting management's commentary on inventory expenses for P+O.
Following the report of third-quarter sales surpassing consensus expectations and the company's subsequent increase in fiscal year guidance for Galafold and Pombiliti, the view is that Amicus' narrative may prove to be highly attractive to potential strategic acquirers in 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
